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Abstract
Background: HAb18G/CD147 plays pivotal roles in invasion by hepatoma cells, but the underlying
mechanism remains unclear. Our previous study demonstrated that overexpression of HAb18G/CD147
promotes invasion by interacting with integrin α3β1. However, it has never been investigated whether
α3β1 is solely responsible for this process or if other integrin family members also interact with HAb18G/
CD147 in human hepatoma cells.
Methods: Human SMMC-7721 and FHCC98 cells were cultured and transfected with siRNA fragments
against HAb18G/CD147. The expression levels of HAb18G/CD147 and integrin α6β1 were determined
by immunofluorescent double-staining and confocal imaging analysis. Co-immunoprecipitation and
Western blot analyses were performed to examine the native conformations of HAb18G/CD147 and
integrin α6β1. Invasion potential was evaluated with an invasion assay and gelatin zymography.
Results:  We found that integrin α6β1 co-localizes and interacts with HAb18G/CD147 in human
hepatoma cells. The enhancing effects of HAb18G/CD147 on invasion capacity and secretion of matrix
metalloproteinases (MMPs) were partially blocked by integrin α6β1 antibodies (P < 0.01). Wortmannin, a
specific phosphatidylinositol kinase (PI3K) inhibitor that reverses the effect of HAb18G/CD147 on the
regulation of intracellular Ca2+ mobilization, significantly reduced cell invasion potential and secretion of
MMPs in human hepatoma cells (P < 0.05). Importantly, no additive effect between Wortmannin and α6β1
antibodies was observed, indicating that α6β1 and PI3K transmit the signal in an upstream-downstream
relationship.
Conclusion: These results suggest that α6β1 interacts with HAb18G/CD147 to mediate tumor invasion
and metastatic processes through the PI3K pathway.
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Background
CD147 is a transmembrane glycoprotein categorized as a
member of the immunoglobulin superfamily (IgSF) [1-4].
CD147 was identified independently in various species
and referenced throughout the literature as EMMPRIN
(Extracellular Matrix Metalloproteinase-Inducer), M6 and
HAb18G (human) [1,2,5], Neurothelin, 5A11 and HT7
(chicken) [6-8], OX47 and CE9 (rat) [3,9], and Basigin,
gp42 (human and mouse) [4,10]. CD147 plays pivotal
roles in the intercellular interactions involved in tumor
metastasis and angiogenesis, spermatogenesis and fertili-
zation [11,12], neural network formation and develop-
ment [13,14], HIV infection, and rheumatoid arthritis
[15,16]. Most importantly, studies from other investiga-
tors and our own laboratory have demonstrated that
CD147 acts as a central factor in the stimulation of matrix
metalloproteinases (MMPs) and promotes tumor inva-
sion. However, intracellular signaling mechanisms
responsible for CD147's stimulation of MMPs and tumor
promoting effects remain incompletely understood.
Integrins are cell surface adhesive receptors composed of
α- and β-chain heterocomplexes that mediate physical
and functional interactions between cells and the extracel-
lular matrix. Variant integrins can interact with different
ligands and vice versa. Integrins thus serve as bidirectional
transducers of extracellular and intracellular signals in the
processes of cell adhesion, proliferation, differentiation,
apoptosis, and tumor progression. Normal adult hepato-
cytes express low levels of only three integrins: α1β1 (a
collagen and laminin receptor), α5β1 (a fibronectin
receptor), and α9β1 (a tenascin receptor). In contrast,
other integrins (such as α2β1, α3β1, α6β1, and α6β4) are
not present in normal hepatocytes, but are expressed in
hepatoma cells. However, the precise roles integrins play
in liver carcinogenesis remain unclear.
In previous studies, CD147 was found to be associated
with integrins α3β1 and α6β1, but not α2β1 and α5β1
[17]. In a recent study, we demonstrated that α3β1 plays
a critical role in CD147-mediated liver carcinogenesis,
indicating that the interaction between CD147 and vari-
ous integrins is a necessary step for their tumor-promoting
effects [18]. However, it is unknown whether α3β1 is
solely responsible for this process or if other integrin fam-
ily members also interact with HAb18G/CD147 in
human hepatoma cells. Given the fact that one of the
most frequent alterations during liver carcinogenesis is de
novo expression of the integrin α6β1 and that the induc-
tion of α6β1 expression is an early event in hepatocellular
carcinogenesis [19-23], it is critical to clarify whether
α6β1 interacts with CD147 and thus contributes to liver
carcinogenesis.
In the present study, we demonstrated that HAb18G/
CD147 interacts with integrin α6β1, activates the PI3K
signal pathway through phosphorylation, and thereby
enhances the invasion potential of hepatoma cells.
Methods
Cell culture
Human SMMC-7721 and FHCC98 cells (both obtained
from the Institute of Cell Biology, Academic Sinica,
Shanghai, China) were cultured with RPMI 1640 medium
(Gibco, New York, USA) supplemented with 10% fetal
bovine serum (FBS, Gibco, New York, USA), 1% penicil-
lin/streptomycin, and 2% L-glutamine at 37°C in a
humidified atmosphere of 5% CO2.
Gene silencing of CD147 by RNA interference, RT-PCR 
and Western blot
The sense sequence for the HAb18G/CD147 small inter-
fering RNA (siRNA) was 5'-GUU CUU CGU GAG UUC
CUC TT-3', 3'-DTD TCA AGA AGC ACU CAA GGA G-5'
(Ambion, USA). FHCC98 and 7721 cells were transfected
with siRNA using Lipofectamine 2000 reagent (Invitro-
gen, USA) according to the manufacturer's instructions.
Silencer-negative control siRNA (sncRNA) (Ambion,
USA) was used as a negative control under similar condi-
tions. Silencing effects of HAb18G/CD147 were examined
by RT-PCR and Western blot.
Forty-eight hours after siRNA transfection, total RNA was
isolated using Trizol (Invitrogen, Carlsbad, CA, USA)
according to the manufacturer's instructions for use in the
analysis of CD147 mRNA levels. The isolation was fol-
lowed by first-strand cDNA synthesis using True Script
reverse transcriptase (BioRad, Hercules, CA, USA). The
cDNA was amplified by PCR using a specific primer set for
CD147 or glyceraldehyde phosphate dehydrogenase
(GAPDH) as an internal control. The sequences of the
upstream and downstream primers were, respectively, as
follows:
Sense: 5'-ACA TCA ACG AGG GGG AGA CG-3'; Antisense:
5'-GGC TTC AGA CAG GCA GGA CA-3' for CD147 (492
bp); Sense: 5'-CTG AAC GGG AAG CTC ACT GG-3'; Anti-
sense: 5'-TGA GGT CCA CCA CCC TGT TG-3' for GAPDH
(313 bp). PCR analysis was performed under the follow-
ing conditions: an initial denaturation at 94°C for 2 min
followed by 25-30 cycles of a 30-sec denaturation step at
94°C, renaturation for 60 sec at 57°C, and extension for
90 sec at 72°C. The amplified products were analyzed by
1% agarose gel electrophoresis followed by GoldView™
staining. Forty-eight hours after siRNA transfection,
FHCC98 and 7721 cells were harvested in a lysis buffer
and equal amounts of cellular proteins were subjected to
SDS-PAGE (10%). Proteins were transferred to polyvinyli-
dene difluoride membranes and blots were probed with
HAb18 mAb (prepared in our laboratory). GAPDH was
chosen as an internal control and the blots were probedBMC Cancer 2009, 9:337 http://www.biomedcentral.com/1471-2407/9/337
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with mouse anti-GAPDH mAb (Chemicon International,
Inc.).
Co-immunoprecipitation and Western blot analyses
The interaction of HAb18G/CD147 with integrin α6β1 in
native cells was detected using the ProFound™ Mamma-
lian Co-Immunoprecipitation Kit (Pierce, USA) according
to the manufacturer's instructions. Briefly, FHCC98 cells
or 7721 cells (1×106) were lysed with M-per reagent. The
lysate was collected onto a coupling gel by four washes
with the co-immunoprecipitation buffer and which were
pre-bound with 200 μg mouse anti-human HAb18G/
CD147 mAb/HAb18 (developed previously in our lab
[24-27]) or 200 μg mouse anti-human α6 mAb (GoH3)
(Santa Cruz, USA) and 200 μg mouse anti-human β1 mAb
(3S3) (Santa Cruz, USA). Bound proteins were eluted
from the coupling gel with elution buffer, and aliquots of
the elution were analyzed by Western blot using goat anti-
human α6 mAb (diluted 1:2000), anti-human β1 anti-
body (diluted 1:2000) or HAb18 (diluted 1:5000). Horse-
radish peroxidase (HRP)-conjugated rabbit anti-goat IgG
(diluted 1:5000; Amersham Pharmacia) was used as the
negative control.
Immunofluorescence and confocal microscopy
Cells were allowed to attach to precoated glass coverslips
overnight. They were fixed the following day in 4% para-
formaldehyde and then blocked with 2% bovine serum
albumin (BSA) in phosphate-buffered saline (PBS) for 0.5
h. Coverslips were incubated with the primary antibodies
(Santa Cruz) at a 1:200 dilution in PBS for 1 h. Primary
antibody-treated cells were washed in PBS and then incu-
bated with Allex594 goat anti-mouse (Invitrogen-Molecu-
lar Probe, USA) or fluorescein isothiocyanate (FITC)-
conjugated donkey anti-goat secondary antibodies (Santa
Cruz, USA) at a 1:500 dilution in PBS for 1 h. Cell nuclei
were dyed with 4,6-diamino-2-phenyl indole (DAPI)
(Invitrogen-Molecular Probe) for 3 min. Finally, the cells
were mounted using glycerol and observed by FV1000
laser scanning confocal microscope (Olympus).
Invasion assay
The assay was performed using chambers with polycar-
bonate filters with 8-μm nominal pore size (Millipore,
USA) coated on the upper side with Matrigel (Becton
Dickinson Labware, USA). The chambers were placed into
a 24-well plate. Hepatoma cells were harvested after 24 h
of siRNA transfection. Five groups of transfected cells
(1×105) were harvested and placed in the upper chamber:
transfected cells alone, cells treated with 10 μg/mL anti-
integrin α6β1 mAb, cells treated with 1 μg/mL Wortman-
nin in 100 μL RPMI 1640 containing 0.1% BSA, sncRNA-
transfected cells (negative control), and untreated cells
(blank control). The lower chamber was filled with 600
μL RPMI 1640 containing 5% FBS and then incubated for
24 h at 37°C in a humidified atmosphere containing 5%
CO2. Cells remaining in the upper chamber were com-
pletely removed by gently swabbing. The number of cells
that passed through the filter and invaded the lower
chamber was determined using a colorimetric crystal vio-
let assay.
Gelatin zymography
Twenty-four hours after siRNA transfection, cells were
treated with antibodies or inhibitors in serum-free
medium. Cells were incubated at 37°C for 20 h. The con-
ditioned medium was collected and separated by 8% acr-
ylamide gels containing 0.1% gelatin. The gels were
incubated in a 2.5% Triton X-100 (Sigma, USA) solution
at room temperature with gentle agitation and then were
soaked in reaction buffer [50 mM Tris-HCl (pH 7.5), 200
mM NaCl, and 10 mM CaCl2] at 37°C overnight. The gels
were stained for 6 h and destained for 0.5 h. The zones of
gelatinolytic activity were revealed by negative staining.
Western blot for Akt phosphorylation
FHCC98 and 7721 cells were harvested in a lysis buffer,
and equal amounts of cellular proteins were subjected to
SDS-PAGE (10%). Proteins were transferred to PVDF
membranes, and blots were probed with phosphorylated
and non-phosphorylated forms of Akt. Blots were washed
3-5 min with Tris-buffered saline/0.1% Tween 20 and
incubated with horseradish peroxidase-conjugated sec-
ondary antibody (1:2000) for 1 h. The membranes were
washed as described above, and the bands detected by
chemilluminescence (Amersham, Freiburg, German).
Statistical analysis
Statistical significance was determined using a one-way
ANOVA analysis or Student's t-test. GraphPad Prism soft-
ware (Cricket Software, Philadelphia, PA) was used for the
above analyses and P values less than 0.05 were consid-
ered significant.
Results
HAb18G/CD147 co-localized with α6β1 integrin on the 
surface of human hepatoma cells
Immunofluorescent double-staining and confocal imag-
ing analysis demonstrated that integrin α6β1 and
HAb18G/CD147 were strongly expressed at the marginal
areas of the two different hepatoma cell lines FHCC98
(Fig. 1) and 7721 (not shown). HAb18G/CD147 signals
co-localized with integrin α6 and β1 on the surface of
HCC cells. The co-localizations were distributed diffusely
throughout the membrane.
HAb18G/CD147 immunoprecipitates with α6β1 integrin in 
human hepatoma cells
To verify whether HAb18G/CD147 interacts with integrin
α6β1 in hepatoma cells, we performed co-immunoprecip-BMC Cancer 2009, 9:337 http://www.biomedcentral.com/1471-2407/9/337
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itation experiments in FHCC98 (Fig. 2) and 7721 (not
shown) cells. As Fig. 2 demonstrates, integrin α6 and β1
subunits co-immunoprecipitate with endogenous
HAb18G/CD147 in FHCC98 cells. The same finding
occurred in 7721 cell lysates (results not shown). The
results indicated that HAb18G/CD147 and α6β1 integrin
interact in their native conformations.
Effects of silencing HAb18G/CD147 on FHCC98 and 7721 
cells
To investigate the role of HAb18G/CD147 in FHCC98
and 7721 cells, RNA interference was used to knock down
the expression of HAb18G/CD147 in these two cell lines.
The HAb18G/CD147-specific siRNA (siCD147) and
sncRNA were tested for their ability to specifically sup-
press HAb18G/CD147. RT-PCR showed that the sncRNA
was incapable of inhibiting HAb18G/CD147 gene expres-
sion, whereas siCD147 could effectively decrease the
mRNA expression of HAb18G/CD147 (Fig. 3A). Similar
results were obtained in 7721 cells (data not shown).
These results were confirmed by Western blot. The protein
expression of HAb18G/CD147 was obviously decreased
in siCD147-transfected cells, but not in sncRNA-trans-
fected cells 48 h after siRNA transfection (Fig. 3B). These
data show that siCD147 treatment effectively decreased
HAb18G/CD147 expression in FHCC98 and 7721 cells.
Integrin α6β1 mediates HAb18G/CD147-induced invasion 
of human hepatoma cells
In order to clarify the functional association of HAb18G/
CD147 with integrin α6β1, the effect of anti-integrin α6
mAb (GoH3) and β1 mAb (3S3) on the invasion of
FHCC98 and 7721 cells were examined in the presence of
HAb18G/CD147 gene silencing. Silencing of the
HAb18G/CD147 gene was achieved by transfection of
FHCC98 and 7721 cells with the HAb18G/CD147-spe-
cific siRNA. To explore the nature of the integrins involved
in HAb18G/CD147-mediated invasion, experiments were
reproduced with blocking antibodies to α6 and β1. As
shown in Fig. 4, there was no significant difference
between the invasive cell numbers of sncRNA-transfected
and blank FHCC98 cells. In contrast, transfection with
sncRNA+GoH3, sncRNA+3S3, and sncRNA+GoH3+3S3
reduced invasive cell numbers by 32.37 ± 14.10%, 31.07
± 4.82%, and 34.89 ± 12.15%, respectively, as compared
to the blank group (P < 0.01). FHCC98 cells transfected
with siHAb18G/CD147 demonstrated significantly
reduced invasive cell numbers by 28.01 ± 5.56% (P  <
0.01), but there was no significant difference in compari-
son to sncRNA+GoH3, sncRNA+3S3, and
sncRNA+GoH3+3S3 cell groups. When cells were treated
with siHAb18G/CD147+GoH3, si-HAb18G/CD147+3S3,
or siHAb18G/CD147+GoH3+3S3, the invasive cell num-
bers were also significantly reduced by 29.21 ± 9.18%,
23.53 ± 6.44%, and 30.28 ± 8.04%, as compared to the
blank group respectively (P < 0.01). In comparison to the
siHAb18G/CD147-treated alone group, no difference was
found. Similar results were obtained in 7721 cells (data
not shown).
After siRNA transfection or treatment with blocking mAb
against integrin α6β1, the supernatants of FHCC98 and
7721 cells were collected to test the levels of MMP secre-
Expression and co-localization of HAb18G/CD147 with  integrin α6 and β1 subunits in FHCC98 cells Figure 1
Expression and co-localization of HAb18G/CD147 
with integrin α6 and β1 subunits in FHCC98 cells. 
FHCC98 cells were double-stained for HAb18G/CD147 
(red) and integrin α6 or β1 (green).
Immunoprecipitation of HAb18G/CD147 and integrin α6 and  β1 subunits in FHCC98 cells Figure 2
Immunoprecipitation of HAb18G/CD147 and 
integrin α6 and β1 subunits in FHCC98 cells. (A) Pre-
cipitates from HAb18G/CD147 immunocomplexes were 
assayed for precipitated integrin α6 and β1 subunits. Precipi-
tates from irrelevant antibody (Mouse IgG) were used as a 
negative control. (B) Expression of HAb18G/CD147 in 
FHCC98 cell lysates by Western blot. (C) Expression of 
integrin α6 and β1 subunits in FHCC98 cell lysates by West-
ern blot. (D) Precipitates from α6β1 immunocomplexes 
were assayed for precipitated HAb18G/CD147. Precipitates 
from irrelevant antibody (Mouse IgG) were used as a nega-
tive control.BMC Cancer 2009, 9:337 http://www.biomedcentral.com/1471-2407/9/337
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tion. Results from the gelatin zymography assay showed
that secretion of both MMP-2 and MMP-9 was signifi-
cantly reduced in FHCC98 and 7721 cells after treatment
with siRNA or antibodies. As shown in Fig. 5, the density
of MMPs in FHCC98 cell lines after treatment with
sncRNA associated with GoH3, 3S3, and GoH3+3S3 was
reduced by 32.55 ± 3.01%, 34.81 ± 6.25%, and 29.09 ±
5.33%, respectively (P < 0.01), as compared to the blank
group. The MMPs levels in siHAb18G/CD147-transfected
FHCC98 cells were also significantly reduced by 21.31 ±
9.98% (P < 0.01), but there was no significant difference
in comparison to the sncRNA+GoH3, sncRNA+3S3, and
sncRNA+GoH3+3S3 groups. The density of MMPs in the
siHAb18G/CD147+GoH3, siHAb18G/CD147+3S3, and
siHAb18G/CD147+GoH3+3S3 groups were also signifi-
cantly reduced by 27.75 ± 5.03%, 32.78 ± 6.30%, and
32.63 ± 11.90% (P < 0.05), respectively, as compared to
the blank group, but no significant difference was found
in comparison to the siHAb18G/CD147-transfected cells
alone. Similar results were obtained in 7721 cells (data
not shown). The results of the invasion assay and gelatin
zymography suggested that there were no additive effects
between HAb18G/CD147 gene silencing and α6β1 anti-
bodies.
PI3K is involved in HAb18G/CD147-elevated invasion of 
human hepatoma cells
We further tested the role of PI3K on HAb18G/CD147-
elevated invasion potential in order to identify the down-
stream signal molecule of the HAb18G/CD147-induced
integrin-involved pathway. Wortmannin, an irreversible
inhibitor of PI3K, was introduced into the invasion and
zymography assays. As shown in Fig. 6, exposure to Wort-
mannin for 40 min inhibited invasion and MMP secre-
tion. In FHCC98 cells, when treated with anti-α6 mAb,
Wortmannin, and associated anti-α6 mAb, the number of
invasive cells were reduced by 32.69 ± 3.06%, 39.22 ±
2.31%, and 41.52 ± 2.33%, respectively, as compared to
the blank control group (P < 0.05) (Fig. 6A and 6B). In
7721 cells, the invasive cell numbers were correspond-
ingly reduced by 27.19 ± 2.08%, 32.98 ± 4.73%, and
24.63 ± 1.69% (P < 0.05) (Fig. 6A and 6C). There were no
significant differences among anti-α6 mAb, Wortmannin,
and Wortmannin-associated anti-α6 mAb.
The results of gelatin zymography also showed that MMP
secretion was significantly reduced in FHCC98 and 7721
cells after treatment with Wortmannin and anti-α6 mAb.
The density of MMPs in the anti-α6 mAb, Wortmannin,
and Wortmannin-associated anti-α6 mAb was reduced by
18.82 ± 7.27%, 19.26 ± 5.21%, and 16.85 ± 4.13%,
respectively, as compared to the blank control group in
FHCC98 cells (P < 0.05) (Fig. 6D and 6E). In 7721 cells,
these same groups correspondingly manifested reduced
MMP density by 22.82 ± 12.32%, 18.18 ± 4.97%, and
20.03 ± 3.74% (P < 0.05) (Fig. 6D and 6F). There were no
significant differences among groups treated with anti-α6
mAb, Wortmannin, or anti-α6 mAb associated with Wort-
mannin (P > 0.05). To identify whether Akt phosphoryla-
tion is involved in the HAb18G/CD147-mediated and
integrin-activated invasion processes of human hepatoma
cells, the expression levels of Akt and P-Akt were tested by
Western blot. The expression levels of P-Akt decreased
57.62 ± 3.61% and 68.06 ± 4.43%, respectively, in
siCD147-transfected FHCC98 cells and siCD147-trans-
fected 7721 cells when compared to expression levels in
sncRNA-transfected cells (P < 0.01, Fig. 7). All these results
suggest that PI3K, a key downstream signal molecule of
integrin  α6β1, is involved in HAb18G/CD147-induced
invasion and metastatic processes of human hepatoma
cells.
Effect of silencing HAb18G/CD147 in FHCC98 and 7721 cells Figure 3
Effect of silencing HAb18G/CD147 in FHCC98 and 7721 cells. Forty-eight hours after siCD147 or sncRNA transfec-
tion of FHCC98 and 7721 cells, HAb18G/CD147 expression levels were examined by RT-PCR (A) and Western blot (B).BMC Cancer 2009, 9:337 http://www.biomedcentral.com/1471-2407/9/337
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Discussion
The invasion process is a complicated and fatal cascade
process in the human hepatoma, but the underlying
molecular events remain largely unknown. Our previous
studies implicated a hepatoma-associated antigen,
HAb18G/CD147, in metastatic processes [28-30]. How-
ever, ligands or receptors for HAb18G/CD147 remain
obscure, and whether HAb18G/CD147 directly interacts
with extra- or intracellular molecules to execute its func-
tion is still unknown. We report here that HAb18G/
CD147, by interacting with α6β1 integrin, enhances the
metastatic potential of hepatoma cells.
In this study, we identified previously uncharacterized
roles for HAb18G/CD147. The expression of integrin
α6β1, a receptor of laminin, was positively related to the
expression of HAb18G/CD147 as indicated the immun-
ofluorescent double-staining and co-immunoprecipita-
tion assay. When the specific antibodies for α 6 and β1
were added to the culture system, effective blocking of the
interaction of HAb18G/CD147 and integrin α6β1
reduced cell invasion and MMP secretion. In siHAb18G-
transfected cells, the addition of specific α6 and β1 anti-
bodies provides no significant additive inhibitory effect.
These results suggest that the enhancing effect of
HAb18G/CD147 on cell invasion and metastatic poten-
tial is mediated through α6β1 integrin.
Integrins serve as the major receptors mediating cell-
matrix adhesion, which plays an important role in the
invasive process of tumor cells. Therefore, it is not surpris-
ing that their interaction with laminin, the major compo-
Invasion of hepatoma cells with or without integrin α6β1 mAbs and siHAb18G/CD147 treatment Figure 4
Invasion of hepatoma cells with or without integrin α6β1 mAbs and siHAb18G/CD147 treatment. (A-D) Matrigel 
invasion assay of FHCC98 (A, B) and 7721 (C, D) cells. Bars represent the mean of triplicate samples; error bars represent 
standard deviation. Data are representative of three independent experiments. ***P < 0.01 versus corresponding cells with no 
antibody treatment.BMC Cancer 2009, 9:337 http://www.biomedcentral.com/1471-2407/9/337
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nent of the basement membrane, serves as a key event in
the tumor invasion and metastatic process [31]. Through
the interaction with integrins, CD147 may regulate the
integrin-laminin association and then influence diverse
processes such as basement membrane formation. The
interaction of CD147 with integrin is conserved in Dro-
sophila and is proposed to play a role in dorsal closure
and extraembryonic membrane apposition [32] as well as
in the maintenance of cellular architecture through
cytoskeletal rearrangement [18]. Within cultured insect
cells, the CD147-integrin interaction is essential for lamel-
lipodia formation. Within retinal cells, disruption of the
CD147-integrin interaction results in aberrant organelle
distribution, including mitochondria, nuclei, and rough
endoplasmic reticulum [18]. The elevated expression lev-
els of both CD147 and integrin α6β1 have been observed
in most metastatic and primary cancers [33,34]. Compar-
ison of normal prostate cells to cancerous cells showed a
preferential pairing of α6 with β4 transitioning to α6 with
β1 in cancer cells [35]. The significance of this transition,
while still speculative, is most likely related to alterations
in downstream signaling events. But there are no reports
about the signal mechanism of the CD147-integrin/α6β1
interaction.
The signaling pathways of the integrins consist of many
cytoskeleton proteins and enzymes, of which focal adhe-
sion kinase (FAK), paxillin, and PI3K are crucial compo-
nents. We previously discovered that FAK, paxillin, and
their phosphorylation levels closely correlate with
HAb18G/CD147 expression in human hepatoma cells
[30]. In the present study, a specific inhibitor of PI3K, a
key protein kinase downstream of integrin α6β1, signifi-
cantly blocked HAb18G/CD147-induced invasion and
MMP secretion of hepatoma cells with or without integrin α6β1 mAbs and siHAb18G/CD147 treatment Figure 5
MMP secretion of hepatoma cells with or without integrin α6β1 mAbs and siHAb18G/CD147 treatment. MMP 
levels of FHCC98 (A, B) and 7721 (A, C) cells. Bars represent the mean of triplicate samples; error bars represent standard 
deviation. Data are representative of three independent experiments. ***P < 0.01, * P < 0.05 versus corresponding cells with 
no antibody treatment.BMC Cancer 2009, 9:337 http://www.biomedcentral.com/1471-2407/9/337
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Effects of a PI3K inhibitor on invasion and MMP secretion of FHCC98 and 7721 cells Figure 6
Effects of a PI3K inhibitor on invasion and MMP secretion of FHCC98 and 7721 cells. (A-C) Matrigel invasion assay 
of FHCC98 (A, B) and 7721 (A, C) cells. (D-F) MMP levels of FHCC98 (D, E) and 7721 (D, F) cells. Bars represent the mean of 
triplicate samples; error bars represent standard deviation. Data are representative of three independent experiments. * P < 
0.05 versus corresponding untreated cells.BMC Cancer 2009, 9:337 http://www.biomedcentral.com/1471-2407/9/337
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MMP release. Our previous data have already demon-
strated that elevated HAb18G/CD147 expression leads to
attenuation of the store-operated Ca2+ entry response to
NO/cGMP and enhanced metastatic potential [26], but
the precise mechanism is still unknown. As a strong
inducer for intracellular Ca2+ store release, IP3 is stimu-
lated by PI3K and activates the Ca2+ channels, allowing
greater Ca2+ influx into the cells. We may speculate that
HAb18G/CD147 enhances the invasion and metastatic
potential of human hepatoma cells via integrin α6β1-
PI3K-Ca2+ signaling pathways.
Conclusion
In the present study, we have identified the interaction of
HAb18G/CD147 with integrin α6β1 in human hepatoma
cells. We demonstrated that HAb18G/CD147 promotes
invasion potential of hepatoma cells by interacting with
integrin α6β1 and further activating its downstream PI3K-
Akt signaling pathway. These findings shed new light onto
the mechanisms underlying HAb18G/CD147-induced
invasion and human hepatoma cell metastatic processes.
The CD147-integrin α6β1 interaction might be a novel
potential target for tumor metastasis therapy.
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